BHG CMO Announcement | Opioid Addiction Treatment Services
Behavioral Health Group Announces Appointment of Kelly Clark, MD, MBA as Chief Medical Officer
DALLAS, TX, July 25, 2012 /PRNewswire/ — The Board of Directors of Behavioral Health Group (“BHG” or “the Company”) today announced the appointment of Kelly J. Clark, MD, MBA, as Chief Medical Officer. Dr. Clark joined BHG July 9, 2012.
Dr. Clark joins BHG with a wide breadth and depth of both clinical and administrative experience. She has practiced addiction medicine and psychiatry throughout the continuum of care, and taught addiction treatment as a faculty member of the University of Massachusetts. She comes to BHG having most recently worked to integrate medical and behavioral health care management as Medical Director at CDPHP. She serves as President of the Kentucky Society of Addiction Medicine, where she has practiced medicine for several years and served as Medical Director of a number of Opioid Treatment Programs.
“I am thrilled to join BHG in the work of providing excellent treatment services to those patients suffering under the epidemic of opioid addiction,” said Clark. “This disease is ravaging individual lives and entire communities across the country. BHG is uniquely situated to bring best practice medication assisted treatment to thousands of patients, and I am excited to work to increase access to evidence-based, physician-directed, team-delivered, high-quality care”.
A Phi Beta Kappa graduate of Coe College in Cedar Rapids, Iowa, Kelly holds a Doctor of Medicine degree from the University of Wisconsin, and a Master of Business Administration with Additional Certification in Health Sector Management from the Fuqua School of Business at Duke University. She is currently on the faculty of the Virginia Tech Carillion School of Medicine. Dr. Clark is a Fellow of the American Society of Addiction Medicine, where she serves as a Director, and is a Distinguished Fellow of the American Psychiatric Association.
BHG’s Chairman and CEO, Michael N. Cannizzaro, said of the appointment: “The Board is delighted to welcome Kelly to BHG’s executive team as Chief Medical Officer. Her talents and experiences will be invaluable in directing the pharmacotherapy and behavioral therapy aspect of our business as she builds the Medical Directorate of our company.”
About Behavioral Health Group
Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) and behavioral therapy (counseling) to treat both the bio-chemical and psycho-social aspects of addiction. In doing so, BHG offers its patients their best shot at successful recovery. With 23 outpatient treatment centers across the midwest/south/southeast, BHG provides a critical service to thousands of individuals and their communities across the country. BHG’s treatment centers are accredited by The Joint Commission.
For more information, call (214) 365-6100, email firstname.lastname@example.org, or visit http://www.bhgrecovery.com.
Behavioral Health Group Contact: James F. Draudt, COO